Pinar Kanlikilicer, Nilay Budeyri, B. S. Akbulut, A. Hortaçsu, Elif Ozkirimli Olmez
{"title":"Dynamic analysis of ß lactamase ligand interaction","authors":"Pinar Kanlikilicer, Nilay Budeyri, B. S. Akbulut, A. Hortaçsu, Elif Ozkirimli Olmez","doi":"10.1109/BIYOMUT.2009.5130306","DOIUrl":null,"url":null,"abstract":"β-lactam antibiotics are the most commonly used antibiotics which cause bacterial cell lysis by inhibiting the enzyme responsible for the cell wall synthesis. Production of β-lactamase enzyme, which catalyzes the hydrolysis of β-lactam ring of β-lactam antibiotics is the most common mechanism of bacterial resistance. β-Lactamase Inhibitory Protein (BLIP), is an effective inhibitor of class A β-lactamases such as TEM-1 and SHV-1. TEM-1 and SHV-1 are the most commonly found β-lactamases and they are responsible for the resistance to β-lactam antibiotics of various pathogenic bacteria. In an effort to elucidate the mechanism of β-lactamase inhibiton by BLIP and to make predictions of binding affinity between these molecules, Molecular Dynamics (MD) simulations were performed on TEM-1 and SHV-1 bound to BLIP and BLIP based peptides. Asp49 residue which is known to play a critical role on binding on BLIP was mutated to Alanine to determine the contribution of this residue to binding. Binding free energy of the TEM-1 and SHV-1 bound BLIP, mutant BLIP (D49A) complexes were estimated by the molecular mechanics Poisson Boltzmann Surface Area method (MM-PBSA). Free energy of binding calculations show that the mutation on D49 causes a decrease in binding affinity for both TEM-1 and SHV-1 β-lactamase.","PeriodicalId":119026,"journal":{"name":"2009 14th National Biomedical Engineering Meeting","volume":"22 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2009-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2009 14th National Biomedical Engineering Meeting","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/BIYOMUT.2009.5130306","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
β-lactam antibiotics are the most commonly used antibiotics which cause bacterial cell lysis by inhibiting the enzyme responsible for the cell wall synthesis. Production of β-lactamase enzyme, which catalyzes the hydrolysis of β-lactam ring of β-lactam antibiotics is the most common mechanism of bacterial resistance. β-Lactamase Inhibitory Protein (BLIP), is an effective inhibitor of class A β-lactamases such as TEM-1 and SHV-1. TEM-1 and SHV-1 are the most commonly found β-lactamases and they are responsible for the resistance to β-lactam antibiotics of various pathogenic bacteria. In an effort to elucidate the mechanism of β-lactamase inhibiton by BLIP and to make predictions of binding affinity between these molecules, Molecular Dynamics (MD) simulations were performed on TEM-1 and SHV-1 bound to BLIP and BLIP based peptides. Asp49 residue which is known to play a critical role on binding on BLIP was mutated to Alanine to determine the contribution of this residue to binding. Binding free energy of the TEM-1 and SHV-1 bound BLIP, mutant BLIP (D49A) complexes were estimated by the molecular mechanics Poisson Boltzmann Surface Area method (MM-PBSA). Free energy of binding calculations show that the mutation on D49 causes a decrease in binding affinity for both TEM-1 and SHV-1 β-lactamase.